Back

ASCO Plenary Jan 2022 - ASCO Plenary Series: January 2022

Jan 25 - Jan 25, 2022 | AlexandriaVAUS

LARVOL is not affiliated with ASCO Plenary Series: January 2022 and all trademarks, logos, and brand names are property of their respective owners

Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID

Showing 1 abstracts linked to Trials

INTRIGUE: A phase III, randomized, open-label study to evaluate the efficacy and safety of ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib

8 Twitter Reactions